Literature DB >> 9668108

Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis.

J L Gervais1, P Seth, H Zhang.   

Abstract

Activation of the p53-mediated DNA damage response induces either G1 cell cycle arrest or apoptosis. The G1 cell cycle arrest is in part caused by the p53-dependent transcriptional activation of the CDK inhibitor, p21(Cip1/Waf1). We report here that human p21 protein is rapidly induced but selectively cleaved during the apoptotic response to gamma-irradiation. Such an event occurred early, well before the morphological appearance of apoptosis. Ectopical expression of p53 in tumor cells alone could induce p21 expression, followed by p21 cleavage and apoptosis. The cleavage of p21 could be reproduced in extracts prepared from irradiated cells or by recombinant caspase-3, suggesting that a caspase-like activity is responsible for this cleavage. p21 binds independently to both CDK2 and proliferation cell nuclear antigen (PCNA). Our studies indicated that p21 cleavage by the caspase-like activity specifically abolished its interaction with PCNA, suggesting that p21 cleavage may interfere with normal PCNA-dependent repair. Our data suggest that p21 may serve as a critical checkpoint regulator for both cell cycle arrest and apoptosis during the p53-mediated DNA damage response. Manipulation of the checkpoint regulators involved in cell cycle arrest and apoptosis may thus provide a novel strategy to cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668108     DOI: 10.1074/jbc.273.30.19207

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Thymocyte apoptosis.

Authors:  Y Yang; J D Ashwell
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Augmented generation of protein fragments during wakefulness as the molecular cause of sleep: a hypothesis.

Authors:  Alexander Varshavsky
Journal:  Protein Sci       Date:  2012-11       Impact factor: 6.725

3.  Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis.

Authors:  Sudesh Agrawal; Munna L Agarwal; Moitreyee Chatterjee-Kishore; George R Stark; Guy M Chisolm
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  Patterns of p21(waf1/cip1) expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas.

Authors:  M J Schwerer; A Sailer; K Kraft; K Baczako; H Maier
Journal:  J Clin Pathol       Date:  2001-11       Impact factor: 3.411

5.  Inhibition of caspase-3 by Survivin prevents Wee1 Kinase degradation and promotes cell survival by maintaining phosphorylation of p34Cdc2.

Authors:  Javier Rivera Guzman; Seiji Fukuda; Louis M Pelus
Journal:  Gene Ther Mol Biol       Date:  2009

6.  Degradation of p21cip1 in cells productively infected with human cytomegalovirus.

Authors:  Z Chen; E Knutson; A Kurosky; T Albrecht
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Integrin α6β4-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues.

Authors:  Seung Hee Jung; Minyoung Lee; Hyun A Park; Hyung Chul Lee; Donghee Kang; Hyun Jung Hwang; Chanho Park; Dong-Min Yu; Yu Ri Jung; Mi-Na Hong; Yong-Nyun Kim; Heon Joo Park; Young-Gyu Ko; Jae-Seon Lee
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

8.  Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo.

Authors:  H Ino; T Chiba
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

Review 9.  Caspases and kinases in a death grip.

Authors:  Manabu Kurokawa; Sally Kornbluth
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

10.  Manipulating cell cycle regulation in the mature cochlea.

Authors:  Ryosei Minoda; Masahiko Izumikawa; Kohei Kawamoto; Hui Zhang; Yehoash Raphael
Journal:  Hear Res       Date:  2007-06-15       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.